Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The Percept™ family of neurostimulators deliver personalized, upgradable therapy, powered by BrainSense™ technology. BrainSense™ technology† uses brain signals to provide a window into a patient's condition, in real time, over time.
Download brochureThe Percept™ PC and Percept™ RC neurostimulators feature BrainSense™ technology, designed to capture brain signals (local field potentials, or LFPs) using the implanted DBS lead. These signals can be recorded simultaneously while delivering therapeutic stimulation, inside and outside the clinic.
You can correlate these brain signals with stimulation and events capturing medication, symptoms, or side effects to deliver personalized, data-driven treatment and adjust as patient needs evolve.
Medtronic’s DBS Therapy is approved for 5 indications: Parkinson’s disease, essential tremor, dystonia*, obsessive-compulsive disorder* (OCD), and epilepsy. Indications vary by product, refer to product labeling for details. *Humanitarian Device: The effectiveness of these devices for the treatment of dystonia and obsessive-compulsive disorder has not been demonstrated.
Get the latest updates about BrainSense™ technology and connect with a rep.
BrainSense™ technology captures brain signals (local field potentials, or LFPs) using the implanted DBS lead. These signals can be recorded simultaneously while delivering therapeutic stimulation, inside and outside the clinic. Clinicians can also correlate these brain signals with stimulation and patient-captured events such as medication, symptoms, or side effects.
The Percept family with BrainSense™ technology is the most complete DBS system with sensing and directionality so you can access data-driven insights to tailor therapy with confidence.
BrainSense™ technology uses brain signals to provide clinicians with objective data to understand the impact of treatment decisions such as medication or stimulation changes.
Read about research on brain sensing and BrainSense™ technology in this scientific compendium.
The first-of-its-kind, SenSight™ directional DBS lead system combines the benefits of directionality with the power of sensing. Built with proprietary materials, components, and processes, the SenSight™ directional lead and SenSight™ extension work seamlessly with the Percept™ neurostimulators to enhance detection of local field potentials (LFPs), which are 1 million times smaller than DBS stimulation pulses.1
Explore BrainSense™ technology real-world insights: the BrainSense™ suite of tools offers decision-making support to select and optimize programming configurations and to maximize therapeutic results over time.
Sign up and access Medtronic medical education information including DBS indications, product information, e-learning modules, webinars, and other therapy-related materials.
Clinician services
800-328-0810
Search by product name or model number.
†The sensing feature of the Percept™ PC and Percept™ RC system is intended for use in patients receiving DBS where chronically recorded bioelectric data may provide useful, objective information regarding patient clinical status. The majority of patients with Parkinson’s disease have an identifiable signal. Signal may not be present or measurable in patients treated for essential tremor, dystonia,* epilepsy or obsessive-compulsive disorder.*
*Humanitarian device: The effectiveness of these devices for the treatment of dystonia or obsessive-compulsive disorder has not been demonstrated.
Neumann WJ, Staub F, Horn A, et al. Deep brain recordings using an implanted pulse generator in Parkinson’s disease. Neuromodulation. 2016;19(1):20–24.